Sign In
Buy WST
$316.31
+4.14 (+1.33%)
At Close: Jun 03, 2026
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
07:30am, Monday, 24'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, In
West Pharmaceutical Services, Inc. (WST) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
03:30pm, Friday, 21'st Feb 2025
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, In
West Announces Second-Quarter Dividend
04:30pm, Thursday, 20'th Feb 2025
EXTON, Pa. , Feb. 20, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Compa
West Pharmaceuticals Takes A Plunge, But May Still Offer Opportunities
01:15am, Monday, 17'th Feb 2025
The price of West Pharmaceutical Services plunged over 38% after it released its Q4 and FY 2024 earnings results on February 13. Shareholders, mostly institutional investors apparently, did not like t
Final Trade: WST, BTC, GLD, ALT
06:32pm, Friday, 14'th Feb 2025
The final trades of the day with the Fast Money traders.
Is WST Stock Undervalued At $200?
08:46am, Friday, 14'th Feb 2025
West Pharmaceutical Services, a global provider of solutions for drugs, biologics, gene therapies, and consumer healthcare products, recently announced its Q4 results, surpassing analysts' expectation
West Pharmaceutical Services, Inc. (WST) Q4 2024 Earnings Call Transcript
03:50pm, Thursday, 13'th Feb 2025
West Pharmaceutical Services, Inc. (NYSE:WST ) Q4 2024 Earnings Conference Call February 13, 2025 9:00 AM ET Company Participants John Sweeney - Vice President of Investor Relations Eric Green - Chair
West Pharma's stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin
01:49pm, Thursday, 13'th Feb 2025
West Pharmaceutical Services Inc.'s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025
West Pharmaceutical Stock Sinks On Weaker Than Expected 2025 Guidance
12:51pm, Thursday, 13'th Feb 2025
On Thursday, West Pharmaceutical Services, Inc. WST reported a fourth-quarter adjusted EPS of $1.82, beating the consensus of $1.72.
West Pharmaceutical forecasts 2025 results below expectations, shares drop
08:25am, Thursday, 13'th Feb 2025
West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong dollar and as the medical equipment maker's clients reduce inventory levels,
West Pharmaceutical Services (WST) Surpasses Q4 Earnings and Revenue Estimates
08:12am, Thursday, 13'th Feb 2025
West Pharmaceutical Services (WST) came out with quarterly earnings of $1.82 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.83 per share a year ago
West Announces Fourth-Quarter and Full-Year 2024 Results
06:00am, Thursday, 13'th Feb 2025
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa.
Will Segmental Performance Drive West Pharmaceutical's Q4 Earnings?
02:41pm, Monday, 10'th Feb 2025
West Pharmaceutical Services WST is scheduled to release fourth-quarter 2024 results on Feb. 13, before the opening bell. In the last reported quarter, the company delivered an earnings beat of 22.52%
West to Host Fourth-Quarter and Full-Year 2024 Conference Call
06:00am, Thursday, 30'th Jan 2025
EXTON, Pa. , Jan. 30, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), global leader in innovative solutions for injectable drug administration, today announced that it will re
West Announces First-Quarter Dividend
12:00pm, Tuesday, 28'th Jan 2025
EXTON, Pa. , Jan. 28, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company
